Global LFA-based Cardiac Competitive Landscape Professional Research Report 2024

Report Format: PDF   |   Report ID: 5685699   |   Published Date: August 2024   |   Pages:  170+  

Research Summary
LFA-based cardiac detection refers to the use of lateral flow immunoassays (LFAs) in the diagnosis of cardiac conditions. LFAs are rapid, low-cost, and easy-to-use diagnostic tools based on immune reactions between antigens and antibodies. In cardiac diagnosis, LFAs can detect cardiac markers, such as troponin, myoglobin, and creatine kinase, in blood samples to confirm the presence of a heart attack or other cardiac diseases. LFA-based cardiac tests are widely used in emergency rooms, clinics, and hospitals for quick and reliable diagnosis of cardiac conditions.
According to DIResearch's in-depth investigation and research, the global LFA-based Cardiac market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of LFA-based Cardiac include Thermo Fisher, Bio-Rad Laboratories, BD, Roche, Hologic, Abbott, Siemens, Danaher, Alere, BioM?(C)rieux, Clinical Diagnostics, LSI, Randox laboratories, Wondfo Biotech etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of LFA-based Cardiac. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global LFA-based Cardiac market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the LFA-based Cardiac market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of LFA-based Cardiac industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of LFA-based Cardiac Include:
Thermo Fisher
Bio-Rad Laboratories
BD
Roche
Hologic
Abbott
Siemens
Danaher
Alere
BioM?(C)rieux
Clinical Diagnostics
LSI
Randox laboratories
Wondfo Biotech
LFA-based Cardiac Product Segment Include:
Troponin I
Troponin T
CK-MB
Myoglobin
Others
LFA-based Cardiac Product Application Include:
Laboratory Testing
Point-of-care Testing
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global LFA-based Cardiac Industry PESTEL Analysis
Chapter 3: Global LFA-based Cardiac Industry Porter's Five Forces Analysis
Chapter 4: Global LFA-based Cardiac Major Regional Market Size and Forecast Analysis
Chapter 5: Global LFA-based Cardiac Market Size and Forecast by Type and Application Analysis
Chapter 6: North America LFA-based Cardiac Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe LFA-based Cardiac Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China LFA-based Cardiac Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) LFA-based Cardiac Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America LFA-based Cardiac Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa LFA-based Cardiac Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global LFA-based Cardiac Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents

1 LFA-based Cardiac Market Overview

1.1 Product Definition and Statistical Scope

1.2 LFA-based Cardiac Product by Type

1.2.1 Global LFA-based Cardiac Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Troponin I

1.2.3 Troponin T

1.2.4 CK-MB

1.2.5 Myoglobin

1.2.6 Others

1.3 LFA-based Cardiac Product by Application

1.3.1 Global LFA-based Cardiac Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Laboratory Testing

1.3.3 Point-of-care Testing

1.4 Global LFA-based Cardiac Market Revenue Analysis (2019-2030)

1.5 LFA-based Cardiac Market Development Status and Trends

1.5.1 LFA-based Cardiac Industry Development Status Analysis

1.5.2 LFA-based Cardiac Industry Development Trends Analysis

2 LFA-based Cardiac Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 LFA-based Cardiac Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global LFA-based Cardiac Market Analysis by Regions

4.1 LFA-based Cardiac Overall Market: 2023 VS 2024 VS 2030

4.2 Global LFA-based Cardiac Revenue and Forecast Analysis (2019-2030)

4.2.1 Global LFA-based Cardiac Revenue and Market Share by Region (2019-2024)

4.2.2 Global LFA-based Cardiac Revenue Forecast by Region (2025-2030)

5 Global LFA-based Cardiac Market Size by Type and Application

5.1 Global LFA-based Cardiac Market Size by Type

5.2 Global LFA-based Cardiac Market Size by Application

6 North America

6.1 North America LFA-based Cardiac Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America LFA-based Cardiac Market Size by Type

6.4 North America LFA-based Cardiac Market Size by Application

6.5 North America LFA-based Cardiac Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe LFA-based Cardiac Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe LFA-based Cardiac Market Size by Type

7.4 Europe LFA-based Cardiac Market Size by Application

7.5 Europe LFA-based Cardiac Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China LFA-based Cardiac Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China LFA-based Cardiac Market Size by Type

8.4 China LFA-based Cardiac Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) LFA-based Cardiac Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) LFA-based Cardiac Market Size by Type

9.4 APAC (excl. China) LFA-based Cardiac Market Size by Application

9.5 APAC (excl. China) LFA-based Cardiac Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America LFA-based Cardiac Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America LFA-based Cardiac Market Size by Type

10.4 Latin America LFA-based Cardiac Market Size by Application

10.5 Latin America LFA-based Cardiac Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa LFA-based Cardiac Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa LFA-based Cardiac Market Size by Type

11.4 Middle East & Africa LFA-based Cardiac Market Size by Application

11.5 Middle East & Africa LFA-based Cardiac Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global LFA-based Cardiac Market Revenue by Key Manufacturers (2020-2024)

12.2 LFA-based Cardiac Competitive Landscape Analysis and Market Dynamic

12.2.1 LFA-based Cardiac Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Thermo Fisher

13.1.1 Thermo Fisher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Thermo Fisher LFA-based Cardiac Product Portfolio

13.1.3 Thermo Fisher LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Bio-Rad Laboratories

13.2.1 Bio-Rad Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Bio-Rad Laboratories LFA-based Cardiac Product Portfolio

13.2.3 Bio-Rad Laboratories LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 BD

13.3.1 BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 BD LFA-based Cardiac Product Portfolio

13.3.3 BD LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Roche

13.4.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Roche LFA-based Cardiac Product Portfolio

13.4.3 Roche LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Hologic

13.5.1 Hologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Hologic LFA-based Cardiac Product Portfolio

13.5.3 Hologic LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Abbott

13.6.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Abbott LFA-based Cardiac Product Portfolio

13.6.3 Abbott LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Siemens

13.7.1 Siemens Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Siemens LFA-based Cardiac Product Portfolio

13.7.3 Siemens LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Danaher

13.8.1 Danaher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Danaher LFA-based Cardiac Product Portfolio

13.8.3 Danaher LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Alere

13.9.1 Alere Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Alere LFA-based Cardiac Product Portfolio

13.9.3 Alere LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 BioM?(C)rieux

13.10.1 BioM?(C)rieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 BioM?(C)rieux LFA-based Cardiac Product Portfolio

13.10.3 BioM?(C)rieux LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Clinical Diagnostics

13.11.1 Clinical Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Clinical Diagnostics LFA-based Cardiac Product Portfolio

13.11.3 Clinical Diagnostics LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 LSI

13.12.1 LSI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 LSI LFA-based Cardiac Product Portfolio

13.12.3 LSI LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Randox laboratories

13.13.1 Randox laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Randox laboratories LFA-based Cardiac Product Portfolio

13.13.3 Randox laboratories LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Wondfo Biotech

13.14.1 Wondfo Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Wondfo Biotech LFA-based Cardiac Product Portfolio

13.14.3 Wondfo Biotech LFA-based Cardiac Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 LFA-based Cardiac Industry Chain Analysis

14.2 LFA-based Cardiac Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 LFA-based Cardiac Typical Downstream Customers

14.4 LFA-based Cardiac Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Publisher: DIResearch
Choose License
Related Reports

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support